Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors

PaperCitations, authors & open-access status

TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 0 citations, 2026 year and green oa status.

0
Citations
2026
Year
green
OA Status

Related on ScholarIQ

Michiel Van De Sande
Author
470M+ articles · free account